Expression of adhesion molecules and activation markers on lymphocytes and monocytes during hemodialysis

Blood Purification

Volumn 15, Issue 2, 1997, Pages 61-76

  Braun, Norbert ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Adhesion molecules; Hemodialysis; Immune system; Lymphocytes; Monocytes

Indexed keywords

CELL ADHESION MOLECULE; CUPROPHANE; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN; POLYSULFONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; LYMPHOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD; CELL ADHESION MOLECULES; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; RENAL DIALYSIS;

EID: 0030989829     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170318     Document Type: Article

References (49)

1. Vanholder R, Van Loo A., Dhondt AM., De Smet R., Ringoir S: Influence of uraemia and haemodialysis on host defence and infection. Nephrol Dial Transplant 1996:11: 593-598.
2. Fleming SJ, Moran DM, Cookslcy WGE, Faoagali JL: Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 1991:22: 251-257.
3. Miller ML: Treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1991:3:803-808.
4. Lee J. Hakim RM. Fcaron DT: Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis. ClinExpImmunol 1984:56:205-214.
5. Thylen P, Lundahl J, Fernvik E. Hed J, Svenson SB. Jacobson SH: Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992; 12:393-400.
6. Amaout MA, Hakim RM., Tcdd RF, Dana N., Colten HR: Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 1985:312:457-462.
7. Himmeifarb J. Zaoui P. Hakim R: Modulation of granulocyte LAM-1 and MAC-1 during dialysis - A prospective. randomized controlled trial. Kidney Int 1992;41:388-395.
8. Chatenoud L. Dugas B. Beaurain G. Touam M. Drueke T. Vasquez A. Galanaud P. Back JF. Delfraissy JF: Presence of preaclivated T cells in hcmodialysed patients: Their possible role in altered immunity. Proc Natl Acad Sci USA 1986:83:7457-7461.
9. Rabb H. Agosti SJ. Pollard S. Bittle PA. Ramirez G: Activated and regulatory T lymphocyte populations in chronic hemodialysis patients. Am J Kidney Dis 1994:24:443-452.
10. Shaw S: Leukocyte Differentiation Antigen Database, Vers 1.10. International Workshop on Leukocyte Differentiation Antigens. Bethcsda. National Institutes of Health. 1994.
11. Landav AL. Muirhead KA: Procedural guidelines for performing int-munophenotyping by flow' cytometry. Clin Immunol Immunopathol 1989:52:48-60.
12. Preliminary' Consort 30 User’s Guide. Vers F: Mountain View. Bee-ton Dickinson Immunocytonietry Systems, 1988.
13. Khan IH. Catto GRD: Long-term complications of dialysis: Infection. Kidney Int 1993:43(suppl 41): S143-S148.
14. TolkofT-Rubin NE, Rubin RH: Uremia and host defences. N Engl J Med 1990:322:770-772.
15. Raska K Jr., Raskova J. Shea SM. Frankel RM, Wood RH. Lifter J. Ghobrial I., Eisenger RP. Homer L: T cell subsets and cellular immunity in end stage renal disease. Am J Med 1983:75:734-740.
16. Knoll R. Rcincl D. Bothc C. Tsolkas P: I lefepilzbcfall von Zunge und Faeces bci dialysepflichtigen Pa-tienten. Z Hautkr 1990:65:476-480.
17. Goldman M. Vanherwcghem JL: Bacterial infections in chronic hemodialysis patients: Epidemiology and pathophysiologic aspects. Adv Nephrol Necker Hosp 1990; 19:315-332.
18. Greene WC, Leonard WJ: The human interleukin-2 receptor. Annu Rev Immunol 1986;4:69-95.
19. Descamps-Latscha B, Herbelin A: Long-term dialysis and cellular immunity: A critical survey. Kidney lnt 1993;43(suppl 41): S135-S142.
20. Glassntan AB: Interleukin-2 and lymphokine activated killer cells: Promises and cautions. Ann Clin LabSci 1989;19:51-55.
21. June CH., Blucstone JA., Nadlcr LM., Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994:15:321-331.
22. Zaoui P. Hakim R: Natural killer cell function in hemodialysis patients: Effect of the dialysis membrane. Kidney Int 1993:43:1298-1305.
23. Akizawa T., Kinugasa E, Koshikawa S: Increased risk of malignancy and blood membrane interaction in patients with uraemia. Nephrol Dial Transplant 1994:9(suppl 2): 162-164.
24. Shaw S, Ziegler A, DeMars R: Specificity of monoclonal antibodies directed against human and murine class 11 histocompatibility antigens as analyzed by binding to HLA-dete-tion mutant cell lines. Hum Immunol 1985:12:191-211.
25. Vey E, Zhang JH, Dayer JM: 1FN-gamma and l.25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J Immunol 1992:149:2040-2046.
26. Dinarello CA: Interleukin-! and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney lnt 1992: 38(suppl 38):S68-S77.
27. Harding CV., Unanuc ER: Quantitation of antigen-presenting cell MHC class il/peptide complexes necessary' forT-cell stimulation. Nature 1990: 346:574-576.
28. Robey E, Allison IP: T-cell activation: Integration of signals from the antigen receptor and costimulatory molecules. Immunol Today 1995; 16:306-310.
29. Chien Y. Davis MM: How ap T-ccll receptors ‘see’ peptidc/MHC complexes. Immunol Today 1993:14: 597-602.
30. Bcvilacqua MP. Nelson RM. Se-lcclins. J Clin Invest 1993:91:379-387.
31. Pereira BJG., Dinarello CA: Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant 1994: 9(suppl 2):60—71.
32. Finn A, Moal N., Rebuck N., Klein N., Strobel S., Elliott M: Changes in neutrophil CDllb/CD18 and L-sc-lectin expression and release of interleukin-8 and elastase in paediatric cardiopulmonary bypass. Agents Actions 1993;38(Spec No):C44-C46.
33. Bcvilacqua MP. Nelson RM. Man-nori G. Cecconi O: Endothelial-leucocyte adhesion molecules in human disease. Annu Rev Med 1994; 45:361-378.
34. Walpola PL. Gotlieb AL, Cybulsky ML, Langille BL: Expression of 1CAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Artcrioscler Thromb Vase Biol 1995:15:2-10.
35. Van Seventer GA, Shimizu Y, Morgan KJ. Shaw S: The LFA-1 ligand ICAM-1 provides an important co-slimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990:144:4579-4586.
36. Becker N, Abel U, Stiepak C. Meuer SC: Frequency of common colds and serum levels of sICAM-1 (CD54). sLFA-3 (CD58) and sIL-2R (CD25). Eur Cytokine Nctw 1992:3: 545-551.
37. Vaddi K. Newton RC: Regulation of monocyte integrin expression by beta-family chemokines. J Immunol 1994:153:4721-4732.
38. Limb GA, Hamblin AS, Wolsten-croft RA. Dumonde DC: Rapid cytokine up-regulation of integrins, complement receptor 1 and HLA-DR on monocytes but not on lymphocytes. Immunology 1992:77:88-94.
39. Combe C, Pourtein M. de Precigout V. Baquey A. Morel D. Potaux L, Vincendcau P, Bczian JH. Aparicio M: Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Am J Kidney Dis 1994:24:437-442.
40. Tielemans CL. Dclvillc JP, Husson CP, Madhoun P. Lambrcchts AM, Goldman M. Vanherwcghem JL: Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 1993:39:158-165.
41. Bonomini M, Stuard S, Carreno MP. Hacffner-Cavaillon N, Alber-tazzi A: Modulation of leukocyte and platelet surface antigens in haemodialysis (abstract). Nephrol Dial Transplant 1995:10:1032.
42. Dameche L., Brunet P., Georges F, André-Pinon S., Buitey S., Bernard D., Sampol J., Berland Y: Effect of mcltspun cellulose diacetatc and po-lysulfone on leukocyte adhesion molcules and complement (abstract). Nephrol Dial Transplant 1995:10:1032.
43. Meerschacrt J, Furie MB: The adhesion molecules used by monocytes for migration across endothelium include CDIla/CD18. CDIIb/ CD 18, and VLA-4 on monocytes and iCAM-l, VCAM-I. and other ligands on endothelium. J Immunol 1995:154:4099-4112.
44. Schindler R, Linnenweber S., Schulze M., Oppermann M., Dinarel-lo CA., Shaldon S., Koch KM: Gene expression of interleukin-Iβ during hemodialysis. Kidney Ini 1993:43: 712-721.
45. Jaschonek K: Hämorrhagische Dia-tlicsc bei Urämie; in Risler T. Franz HE (eds): Klinische Nephrologie. Landsberg. Ecomed. 1993. pp X-5.1/l-X-5.1/8.
46. Barnstable CJ, Bodmer WF. Brown G, Galfre G. Milstein C, Williams AF. Ziegler A: Production of monoclonal antibodies to group A erythrocytes, H1. A and other human cell surface antigens - New tools for genetic analysis. Cell 1978;14:9-20.
47. Müller GA., Müller CA., Markovic-Lipkovski J, Kilper RB., Risler T: Renal, major histocompatibility complex antigens and cellular components in rapidly progressive glomerulonephritis identified by monoclonal antibodies. Nephron 1988:49:132-139.
48. Schneider EM. Pawelec G. LiangRu S. Bühring HJ. Wemet P: Generation of CD4-positivc suppressor T cells from mixed lymphocyte cultures in the presence of inicrlcukin-2 receptor antibody Tü69. Transplan-tation 1987:44:295-302.
49. Pawclec G., Ziegler A, Wemet P: Dissection of human allostimulato-ry determinants with cloned T cells: Stimulation inhibition by monoclonal antibodies TÜ22. 34. 36, 37, 39, 43, and 58 against distinct human MHC class II molecules. Hum Immunol 1985:12:165-176